Rifat Pamukcu Insider Trading

Name: Rifat Pamukcu insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Jun 17, 2026): Grant/Award of 3,135 APRE shares.

Get alerted when insiders trade APRE

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Filed	Company	Transaction	Shares	Value
Jun 17, 2026	Aprea Therapeutics, Inc. (APRE)	Grant/Award	3,135	n/a
Jun 9, 2025	Aprea Therapeutics, Inc. (APRE)	Grant/Award	1,045	n/a
Jun 21, 2024	Aprea Therapeutics, Inc. (APRE)	Grant/Award	1,045	n/a
Aug 25, 2023	Aprea Therapeutics, Inc. (APRE)	Conversion	49,280	n/a
Aug 1, 2022	Aprea Therapeutics, Inc. (APRE)	Grant/Award	5,995	n/a

Loading insider data...